IL-1R8 acts as an immune checkpoint in CD8+T cells, limiting cytokine-induced anti-tumor immune responses

被引：0

作者：

Supinol, Domenico ^{[1
]}

Garuti, Roberto ^{[2
]}

Mariancini, Andrea ^{[2
]}

Perucchini, Chiara ^{[3
]}

Carnevale, Silvia ^{[1
]}

Ponzetta, Andrea ^{[4
]}

Colombo, Federico Simone ^{[5
]}

Magrini, Elena ^{[1
]}

Rigatelli, Anna ^{[1
]}

Minute, Luna Cordeiro ^{[2
]}

Mapelli, Sarah ^{[1
]}

Molgora, Martina ^{[6
]}

Scavello, Francesco ^{[1
]}

Di Ceglie, Irene ^{[1
]}

Pezone, Giovanni ^{[1
]}

Falcone, Laura ^{[3
]}

Casucci, Monica ^{[3
]}

Lugli, Enrico ^{[1
]}

Jaillon, Sebastien ^{[1
,2
]}

Mantovani, Alberto ^{[1
,2
,7
]}

Garlanda, Cecilia ^{[1
,2
]}

机构：

[1] IRCCS Humanitas Res Hosp, Milan, Italy

[2] Humanitas Univ, Pieve Emanuele, Italy

[3] IRCCS San Raffaele Sci Inst, Milan, Italy

[4] Karolinska Univ Hosp, Stockholm, Sweden

[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[6] Washington Univ, Sch Med, St Louis, MO USA

[7] Queen Mary Univ London, London, England

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

683 - WS48

引用

页码：344 / 344

页数：1

共 50 条

[31] Intratumor adoptive transfer of IL-12 mRNA transiently engineered anti-tumor CD8+T cells
Etxeberria, Inaki
Bolanos, Elixabet
Teijeira, Alvaro
Azpilicueta, Arantza
Ignacio Quetglas, Jose
Rodriguez Sanchez-Paulete, Alfonso
Otano, Itziar
Mancheno, Uxua
Hervas-Stubbs, Sandra
Inoges, Susana
Garasa, Saray
Alvarez, Maite
Berraondo, Pedro
Melero, Ignacio
CANCER RESEARCH, 2019, 79 (13)
[32] TARGETING WILDTYPE IL-2 TO CD8 T CELLS INDUCES POTENT ANTI-TUMOR IMMUNE RESPONSES AND DECREASES IL-2 MEDIATED TOXICITY
Ramasamy, Selvi
Nardozzi, Joanathan
Boi, Shannon
Swain, Joanna
Coyle, Anthony
Gulla, Stefano
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1141 - A1141
[33] Riplet regulates effector function of CD8 T cells and suppresses T cell-mediated anti-tumor immune responses
Iwamoto, Asuka
Tsukamoto, Hirotake
Nakayama, Hideki
Oshiumi, Hiroyuki
CANCER SCIENCE, 2022, 113
[34] YTHDF2 promotes tumor immune evasion by inhibiting CD8+T cell-mediated anti-tumor immunity
Ma, Shoubao
Xiao, Sai
Caligiuri, Michael
Yu, Jianhua
JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
[35] Roles of CD11c+ T cells in anti-tumor immune responses
Chiba, M.
Nakano, N.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 222 - 222
[36] Multiple roles for CD4+ T cells in anti-tumor immune responses
Kennedy, Richard
Celis, Esteban
IMMUNOLOGICAL REVIEWS, 2008, 222 : 129 - 144
[37] Immunoswitch particles target activation of anti-tumor CD8+T cells to inhibit tumor growth
Kosmides, Alyssa
Sidhom, John-William
Fraser, Andrew
Bessell, Catherine
Schneck, Jonathan
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[38] INVESTIGATION OF CD8+T CELL INFILTRATION AND INFLAMMATION IN IMMUNE CHECKPOINT INHIBITOR-INDUCED COLITIS
Xiao, Ted G.
Seagle, Madeline
Parrott, Clifton
Aggarwal, Vanya
Russell, Gregory B.
Li, Wencheng
Lycan, Thomas
Rejeski, Jared
GASTROENTEROLOGY, 2023, 164 (06) : S1005 - S1006
[39] Group 2 innate lymphoid cells boost CD8+ T-cell activation in anti-tumor immune responses
Wen, Jing
Cheng, Shipeng
Wang, Ran
Huang, Yuying
Xu, Long
Ma, Liyan
Ling, Zhiyang
Xu, Jinfu
Zhao, Deping
Zhang, Yaguang
Sun, Bing
ONCOIMMUNOLOGY, 2023, 12 (01):
[40] Tumor-secreted FGF21 acts as an immune suppressorby rewiring cholesterol metabolism of CD8+T cells
Hu, Cegui
Qiao, Wen
Li, Xiang
Ning, Zhi-kun
Liu, Jiang
Dalangood, Sumiya
Li, Hanjun
Yu, Xiang
Zong, Zhen
Wen, Zhenke
Gui, Jun
CELL METABOLISM, 2024, 36 (03) : 630 - 647.e8

← 1 2 3 4 5 →